Lastraioli, Elena
Iorio, Jessica
Piazza, Francesco
Capitani, Chiara
Santillo, Michele
Duranti, Claudia
Bianchi, Simonetta
Meattini, Icro
Fraser, Scott P.
Djamgoz, Mustafa B. A.
Becchetti, Andrea
Arcangeli, Annarosa
Funding for this research was provided by:
Università degli Studi di Firenze (RICATEN24, RICATEN24)
Regione Toscana (MutCoP, MutCoP)
Associazione Italiana per la Ricerca (1662, 15627, 21510)
European Union - NextGenerationEU - National Recovery and Resilience Plan, Mission 4 Component 2 - Investment 1.5 (THE - Tuscany Health Ecosystem - ECS00000017 - CUP B83C22003920001)
European Union, National Recovery and Resilience Plan, Mission 4 Component 2 – Investment 1.4 (National Center for Gene Therapy and Drugs based on RNA Technology - NextGenerationEU – Project Code CN00000041-CUP B13C22001010001)
Article History
Received: 10 August 2024
Accepted: 15 January 2025
First Online: 26 January 2025
Declarations
:
: All the patients were enrolled after informed written consent. The study was approved by the local Ethical Committee of Azienda Ospedaliero-Universitaria Careggi (BIO.16.028).
: Not applicable.
: The authors declare no competing interests.